Logo image of KRO

KRONOS WORLDWIDE INC (KRO) Stock Fundamental Analysis

NYSE:KRO - New York Stock Exchange, Inc. - US50105F1057 - Common Stock - Currency: USD

7.4  -0.16 (-2.12%)

After market: 7.4 0 (0%)

Fundamental Rating

5

KRO gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 85 industry peers in the Chemicals industry. KRO has an average financial health and profitability rating. KRO has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

KRO had positive earnings in the past year.
In the past year KRO had a positive cash flow from operations.
Of the past 5 years KRO 4 years were profitable.
Each year in the past 5 years KRO had a positive operating cash flow.
KRO Yearly Net Income VS EBIT VS OCF VS FCFKRO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

1.2 Ratios

KRO has a Return On Assets of 4.50%. This is in the better half of the industry: KRO outperforms 75.29% of its industry peers.
KRO's Return On Equity of 10.55% is fine compared to the rest of the industry. KRO outperforms 76.47% of its industry peers.
KRO has a better Return On Invested Capital (6.67%) than 65.88% of its industry peers.
Industry RankSector Rank
ROA 4.5%
ROE 10.55%
ROIC 6.67%
ROA(3y)2.41%
ROA(5y)3.2%
ROE(3y)5.13%
ROE(5y)7.28%
ROIC(3y)N/A
ROIC(5y)N/A
KRO Yearly ROA, ROE, ROICKRO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

With a decent Profit Margin value of 4.57%, KRO is doing good in the industry, outperforming 64.71% of the companies in the same industry.
KRO's Profit Margin has declined in the last couple of years.
The Operating Margin of KRO (6.43%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of KRO has declined.
KRO has a Gross Margin of 19.04%. This is in the lower half of the industry: KRO underperforms 67.06% of its industry peers.
KRO's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.43%
PM (TTM) 4.57%
GM 19.04%
OM growth 3Y-12.41%
OM growth 5Y-5.03%
PM growth 3Y-7.77%
PM growth 5Y-1.91%
GM growth 3Y-6.11%
GM growth 5Y-3.12%
KRO Yearly Profit, Operating, Gross MarginsKRO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

4

2. Health

2.1 Basic Checks

KRO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for KRO remains at a similar level compared to 1 year ago.
The number of shares outstanding for KRO has been reduced compared to 5 years ago.
KRO has a worse debt/assets ratio than last year.
KRO Yearly Shares OutstandingKRO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
KRO Yearly Total Debt VS Total AssetsKRO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 1.90 indicates that KRO is not a great score, but indicates only limited risk for bankruptcy at the moment.
KRO has a Altman-Z score (1.90) which is comparable to the rest of the industry.
KRO has a debt to FCF ratio of 11.80. This is a negative value and a sign of low solvency as KRO would need 11.80 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 11.80, KRO is in line with its industry, outperforming 56.47% of the companies in the same industry.
KRO has a Debt/Equity ratio of 0.53. This is a neutral value indicating KRO is somewhat dependend on debt financing.
KRO has a Debt to Equity ratio (0.53) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 11.8
Altman-Z 1.9
ROIC/WACC0.72
WACC9.2%
KRO Yearly LT Debt VS Equity VS FCFKRO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 2.32 indicates that KRO has no problem at all paying its short term obligations.
The Current ratio of KRO (2.32) is better than 68.24% of its industry peers.
KRO has a Quick Ratio of 2.32. This is a bad value and indicates that KRO is not financially healthy enough and could expect problems in meeting its short term obligations.
KRO has a Quick ratio (0.94) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 0.94
KRO Yearly Current Assets VS Current LiabilitesKRO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 141.86% over the past year.
KRO shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -24.83% yearly.
The Revenue has grown by 13.24% in the past year. This is quite good.
Measured over the past years, KRO shows a small growth in Revenue. The Revenue has been growing by 1.74% on average per year.
EPS 1Y (TTM)141.86%
EPS 3Y-43.16%
EPS 5Y-24.83%
EPS Q2Q%-140%
Revenue 1Y (TTM)13.24%
Revenue growth 3Y-0.91%
Revenue growth 5Y1.74%
Sales Q2Q%5.75%

3.2 Future

Based on estimates for the next years, KRO will show a very strong growth in Earnings Per Share. The EPS will grow by 99.26% on average per year.
Based on estimates for the next years, KRO will show a small growth in Revenue. The Revenue will grow by 2.83% on average per year.
EPS Next Y402.19%
EPS Next 2Y157.32%
EPS Next 3Y99.26%
EPS Next 5YN/A
Revenue Next Year1.96%
Revenue Next 2Y4.62%
Revenue Next 3Y2.83%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
KRO Yearly Revenue VS EstimatesKRO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
KRO Yearly EPS VS EstimatesKRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 1.5

6

4. Valuation

4.1 Price/Earnings Ratio

KRO is valuated quite expensively with a Price/Earnings ratio of 41.11.
Based on the Price/Earnings ratio, KRO is valued a bit more expensive than the industry average as 64.71% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 28.10. KRO is valued slightly more expensive when compared to this.
With a Price/Forward Earnings ratio of 8.19, the valuation of KRO can be described as very reasonable.
84.71% of the companies in the same industry are more expensive than KRO, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.74, KRO is valued rather cheaply.
Industry RankSector Rank
PE 41.11
Fwd PE 8.19
KRO Price Earnings VS Forward Price EarningsKRO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of KRO indicates a somewhat cheap valuation: KRO is cheaper than 78.82% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, KRO is valued a bit cheaper than the industry average as 65.88% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 19.8
EV/EBITDA 6.74
KRO Per share dataKRO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as KRO's earnings are expected to grow with 99.26% in the coming years.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2Y157.32%
EPS Next 3Y99.26%

5

5. Dividend

5.1 Amount

KRO has a Yearly Dividend Yield of 2.69%. Purely for dividend investing, there may be better candidates out there.
In the last 3 months the price of KRO has falen by -21.69%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
KRO's Dividend Yield is a higher than the industry average which is at 3.81.
KRO's Dividend Yield is comparable with the S&P500 average which is at 2.43.
Industry RankSector Rank
Dividend Yield 2.69%

5.2 History

The dividend of KRO decreases each year by -7.80%.
KRO has been paying a dividend for at least 10 years, so it has a reliable track record.
KRO has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-7.8%
Div Incr Years0
Div Non Decr Years13
KRO Yearly Dividends per shareKRO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

64.04% of the earnings are spent on dividend by KRO. This is not a sustainable payout ratio.
DP64.04%
EPS Next 2Y157.32%
EPS Next 3Y99.26%
KRO Yearly Income VS Free CF VS DividendKRO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M
KRO Dividend Payout.KRO Dividend Payout, showing the Payout Ratio.KRO Dividend Payout.PayoutRetained Earnings

KRONOS WORLDWIDE INC

NYSE:KRO (5/5/2025, 8:22:42 PM)

After market: 7.4 0 (0%)

7.4

-0.16 (-2.12%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-06 2025-03-06/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners16.2%
Inst Owner Change-0.08%
Ins Owners0.11%
Ins Owner Change0.04%
Market Cap851.30M
Analysts46
Price Target10.2 (37.84%)
Short Float %4.36%
Short Ratio3.99
Dividend
Industry RankSector Rank
Dividend Yield 2.69%
Yearly Dividend0.48
Dividend Growth(5Y)-7.8%
DP64.04%
Div Incr Years0
Div Non Decr Years13
Ex-Date03-11 2025-03-11 (0.05)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-132.5%
Min EPS beat(2)-188.88%
Max EPS beat(2)-76.11%
EPS beat(4)2
Avg EPS beat(4)128.2%
Min EPS beat(4)-188.88%
Max EPS beat(4)766.34%
EPS beat(8)3
Avg EPS beat(8)-0.85%
EPS beat(12)5
Avg EPS beat(12)-2.79%
EPS beat(16)7
Avg EPS beat(16)-3.24%
Revenue beat(2)0
Avg Revenue beat(2)-15.49%
Min Revenue beat(2)-15.74%
Max Revenue beat(2)-15.25%
Revenue beat(4)1
Avg Revenue beat(4)-9.16%
Min Revenue beat(4)-15.74%
Max Revenue beat(4)3.09%
Revenue beat(8)3
Avg Revenue beat(8)-3.87%
Revenue beat(12)6
Avg Revenue beat(12)-1.44%
Revenue beat(16)8
Avg Revenue beat(16)-1.25%
PT rev (1m)0%
PT rev (3m)-16.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)12.96%
EPS NY rev (1m)0%
EPS NY rev (3m)6.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.49%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.3%
Valuation
Industry RankSector Rank
PE 41.11
Fwd PE 8.19
P/S 0.45
P/FCF 19.8
P/OCF 11.74
P/B 1.04
P/tB 1.05
EV/EBITDA 6.74
EPS(TTM)0.18
EY2.43%
EPS(NY)0.9
Fwd EY12.22%
FCF(TTM)0.37
FCFY5.05%
OCF(TTM)0.63
OCFY8.52%
SpS16.4
BVpS7.1
TBVpS7.08
PEG (NY)0.1
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.5%
ROE 10.55%
ROCE 8.44%
ROIC 6.67%
ROICexc 7.2%
ROICexgc 7.22%
OM 6.43%
PM (TTM) 4.57%
GM 19.04%
FCFM 2.28%
ROA(3y)2.41%
ROA(5y)3.2%
ROE(3y)5.13%
ROE(5y)7.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-13.41%
ROICexcg growth 5Y-3.71%
ROICexc growth 3Y-13.47%
ROICexc growth 5Y-3.75%
OM growth 3Y-12.41%
OM growth 5Y-5.03%
PM growth 3Y-7.77%
PM growth 5Y-1.91%
GM growth 3Y-6.11%
GM growth 5Y-3.12%
F-Score6
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 11.8
Debt/EBITDA 2.31
Cap/Depr 45.81%
Cap/Sales 1.56%
Interest Coverage 3.18
Cash Conversion 39.04%
Profit Quality 49.88%
Current Ratio 2.32
Quick Ratio 0.94
Altman-Z 1.9
F-Score6
WACC9.2%
ROIC/WACC0.72
Cap/Depr(3y)85.77%
Cap/Depr(5y)95.93%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)141.86%
EPS 3Y-43.16%
EPS 5Y-24.83%
EPS Q2Q%-140%
EPS Next Y402.19%
EPS Next 2Y157.32%
EPS Next 3Y99.26%
EPS Next 5YN/A
Revenue 1Y (TTM)13.24%
Revenue growth 3Y-0.91%
Revenue growth 5Y1.74%
Sales Q2Q%5.75%
Revenue Next Year1.96%
Revenue Next 2Y4.62%
Revenue Next 3Y2.83%
Revenue Next 5YN/A
EBIT growth 1Y302.5%
EBIT growth 3Y-13.2%
EBIT growth 5Y-3.37%
EBIT Next Year71.04%
EBIT Next 3Y30.35%
EBIT Next 5YN/A
FCF growth 1Y202.63%
FCF growth 3Y-33.75%
FCF growth 5Y-16.38%
OCF growth 1Y1218.18%
OCF growth 3Y-29.45%
OCF growth 5Y-14.67%